Please upgrade your browser.
The drugs, Sutent, Nexavar, Avastin and Torisel, havent yet been approved by the National Institute for Health and Clinical Excellence (Nice) for use in the NHS.
S. Duke Herrell, M.D., associate professor of Urologic Surgery at Vanderbilt-Ingram Cancer Center, has performed the first robotic laparoscopic kidney cancer surgery at Vanderbilt University Medical Center.
Afinitor is being studied in multiple cancer types including advanced kidney, breast and neuroendocrine tumors and lymphoma.
Bayer HealthCare and the Association of German Medical Journalists (VDMJ) have jointly announced the 2009 Advances in Renal Cancer Journalists Award Europe, which will honor journalists who have dealt with the issue of renal cancer in a critical and objective manner.
46-year-old Tim Buehner has been battling kidney cancer since last February.
The National Comprehensive Cancer Network (NCCN) has been awarded a $4 million grant from Wyeth Pharmaceuticals to support clinical studies of temsirolimus (Torisel(R),
Jack Rosser of South Gloucestershire. Rosser has advanced kidney cancer and would likely benefit from Sutent, a drug widely used in the United States for such patients. Rosser's doctor has said that Sutent could well add years to his life. However, as Bloomberg reports, "The U.K.'s National Health Service (NHS) says that's not worth the expense."
Predicting all of the winners and losers from health-care reform is almost impossible at this stage.
A prototype device employs the same magnetic phenomenon used to write data to computer hard drives.
NICE will announce a U-turn over its ban on certain kidney cancer drugs.
|Powered by NeonCRM|